Imaging of dopamine transporters: Biomarker for progression in Parkinson's disease

被引：0
|
作者：
Innis, RB [1 ]
Seibyl, J
Marek, K
机构：
[1] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA
[3] Yale Univ, Sch Med, Dept Neurol & Diagnost Radiol, New Haven, CT 06510 USA
来源：
CNS DRUG REVIEWS | 2000年 / 6卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [21] Imaging of dopamine transporters and D2 receptors in patients with Parkinson’s disease and multiple system atrophy
    G. M. Knudsen
    M. Karlsborg
    G. Thomsen
    K. Krabbe
    L. Regeur
    T. Nygaard
    C. Videbæk
    L. Werdelin
    European Journal of Nuclear Medicine and Molecular Imaging, 2004, 31 : 1631 - 1638
  • [22] SPECT Imaging of Dopamine Transporters With 99mTc-TRODAT-1 in Major Depression and Parkinson's Disease
    Wu, Hao
    Lou, Cen
    Huang, Zhongke
    Shi, Guohua
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2011, 23 (01) : 63 - 67
  • [23] Imaging of dopamine transporters and D2 receptors in patients with Parkinson's disease and multiple system atrophy
    Knudsen, GM
    Karlsborg, M
    Thomsen, G
    Krabbe, K
    Regeur, L
    Nygaard, T
    Videbæk, C
    Werdelin, L
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (12) : 1631 - 1638
  • [24] Multimodal imaging of neuromelanin and dopamine transporters in Parkinson's disease reveals asymmetrical relationships within the nigrostriatal system
    Lao-Kaim, N. P.
    Martin-Bastida, A.
    Roussakis, A-A.
    Searle, G.
    Xing, Y.
    Gunn, R.
    Schwarz, S. T.
    Auer, D. P.
    Piccini, P.
    Barker, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 99 - 99
  • [25] Potential role of retina as a biomarker for progression of Parkinson's disease
    Tian, Tian
    Zhu, Xiao-Hua
    Liu, Yun-Hai
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2011, 4 (04) : 433 - 438
  • [26] Substantia nigra echogenicity and imaging of striatal dopamine transporters in Parkinson's disease: A cross-sectional study
    Bor-Seng-Shu, Edson
    Pedroso, Jose Luiz
    Felicio, Andre C.
    de Andrade, Daniel Ciampi
    Teixeira, Manoel Jacobsen
    Braga-Neto, Pedro
    Batista, Ilza Rosa
    Povoas Barsottini, Orlando Graziani
    Borges, Vanderci
    Ferraz, Henrique Ballalai
    Shih, Ming Chi
    Bressan, Rodrigo A.
    Franco de Andrade, Luiz Augusto
    Walter, Uwe
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (05) : 477 - 481
  • [27] Parkinson's Progression Markers Initiative (PPMI): Investigating Biomarker Driven Parkinson's disease (PD) Progression
    McMahon, B.
    Siderowf, A.
    Simuni, T.
    Tanner, C.
    Mollenhauer, B.
    Coffey, C.
    Galasko, D.
    Poston, K.
    Chahine, L.
    Dobkin, R.
    Foroud, T.
    Kieburtz, K.
    Weintraub, D.
    Merchant, K.
    Frasier, M.
    Sherer, T.
    Chowdury, S.
    Brown, E.
    Alcalay, R.
    Videnovic, A.
    Fabrizio, K.
    Flagg, E.
    Stanley, C.
    Marek, K.
    MOVEMENT DISORDERS, 2024, 39 : S331 - S331
  • [28] Dopamine receptors in Parkinson's disease:: Imaging studies
    Stoessl, AJ
    de la Fuente-Fernández, R
    PARKINSON'S DISEASE, 2003, 91 : 65 - 71
  • [29] Influence of dopamine, noradrenaline, and serotonin transporters on the pharmacogenetics of Atremorine in Parkinson's disease
    Cacabelos, Ramon
    Carrera, Ivan
    Martinez, Olaia
    Naidoo, Vinogran
    Cacabelos, Natalia
    Aliev, Gjumrakch
    Carril, Juan C.
    DRUG DEVELOPMENT RESEARCH, 2021, 82 (05) : 695 - 706
  • [30] Imaging endpoints reflect Parkinson's disease progression: NO
    Ahlskog, JE
    MOVEMENT DISORDERS, 2004, 19 : S15 - S15
12345